
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lilie Lin to discuss radiotherapy and novel agents in gynecologic cancers. Dr. Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center where she focuses on the management of gynecologic malignancies. She is the principal investigator of multiple clinical trials testing novel agents combined with radiotherapy for gyn malignancies; she is also interested in using novel PET radiotracers to interrogate the tumor microenvironment. Read her article, “Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin,” here: https://ijgc.bmj.com/content/early/2020/03/18/ijgc-2020-001227
By BMJ Group5
2323 ratings
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lilie Lin to discuss radiotherapy and novel agents in gynecologic cancers. Dr. Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center where she focuses on the management of gynecologic malignancies. She is the principal investigator of multiple clinical trials testing novel agents combined with radiotherapy for gyn malignancies; she is also interested in using novel PET radiotracers to interrogate the tumor microenvironment. Read her article, “Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin,” here: https://ijgc.bmj.com/content/early/2020/03/18/ijgc-2020-001227

37 Listeners

52 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

14 Listeners

3 Listeners

3 Listeners

23 Listeners